secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunovant, Inc. (IMVT)
CIK:        0001764013
Form:       8-K
Filed at:   2026-09-03T21:05:38+00:00
Accession:  0001764013-26-000106
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Immunovant annual meeting: directors elected, E&Y ratified, say-on-pay approved
-------------------------------------------------------------------------------

- 198,373,370 shares represented (~96% of eligible) at Sept 2, 2026 annual meeting.
- Directors Bauer, Hughes, Susman elected with 162.9M, 174.1M, 181.6M votes for, respectively.
- Ernst & Young ratified as independent auditor for FY ending March 31, 2027 (198.1M for).
- Non-binding say-on-pay approved: 180.8M for, 8.4M against, 91.9K abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1764013/000176401326000106/0001764013-26-000106-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1764013/000176401326000106/imvt-20260902.htm
  HTML page:      https://secwatch.observer/filing/0001764013-26-000106

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer